Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Multiple Sclerosis

  Free Subscription

Articles published in Eur Neurol

Retrieve available abstracts of 13 articles:
HTML format

Single Articles

    January 2023
  1. ZOHAR DN, Magalashvili D, Dreyer-Alster S, Hoffmann C, et al
    Radiological Disease Activity in Secondary Progressive Multiple Sclerosis.
    Eur Neurol. 2023 Jan 3:1-5. doi: 10.1159/000527720.
    PubMed     Abstract available

    December 2022
  2. ARROYO-PEREIRO P, Munoz-Vendrell A, Bau L, Matas E, et al
    Influence of Cardiovascular Risk Factors in Early Relapsing-Remitting Multiple Sclerosis: A Retrospective Analysis.
    Eur Neurol. 2022 Dec 5:1-5. doi: 10.1159/000527673.
    PubMed     Abstract available

    January 2022
  3. KARAASLAN Z, Kurtuncu M, Akcay HI, Gunduz T, et al
    CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients.
    Eur Neurol. 2022;85:69-71.

  4. TATU L, Bogousslavsky J
    Treatments in Neurology: The Winding Road from 1897 to 2022.
    Eur Neurol. 2022;85:367-370.
    PubMed     Abstract available

    November 2021
  5. BARREIRO-GONZALEZ A, Sanz MT, Carratala-Bosca S, Perez-Miralles F, et al
    Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis.
    Eur Neurol. 2021 Nov 17:1-10. doi: 10.1159/000519772.
    PubMed     Abstract available

  6. HEIDLER F, Baldt J, Frahm N, Langhorst SE, et al
    Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
    Eur Neurol. 2021 Nov 5:1-8. doi: 10.1159/000519582.
    PubMed     Abstract available

    May 2021
  7. SZILASIOVA J, Rosenberger J, Fedicova M, Mikula P, et al
    Neurofilament Light Chain Levels Are Associated with Disease Activity Determined by No Evident Disease Activity in Multiple Sclerosis Patients.
    Eur Neurol. 2021 May 25:1-8. doi: 10.1159/000515806.
    PubMed     Abstract available

    April 2021
  8. ARICI DUZ O, Saatci O, Karakulak EZ, Birday E, et al
    Olfactory Dysfunction and Cognition in Radiologically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis.
    Eur Neurol. 2021 Apr 8:1-8. doi: 10.1159/000514433.
    PubMed     Abstract available

  9. UZUNKOPRU C, Beckmann Y, Ture S
    Long-Term Effectiveness of Fingolimod for Multiple Sclerosis in a Real-World Clinical Setting.
    Eur Neurol. 2021 Apr 7:1-6. doi: 10.1159/000514828.
    PubMed     Abstract available

    March 2021
  10. ALHOMOUD MA, Khan AS, Alhomoud I
    The Potential Preventive Effect of Pregnancy and Breastfeeding on Multiple Sclerosis.
    Eur Neurol. 2021 Mar 19:1-14. doi: 10.1159/000514432.
    PubMed     Abstract available

    October 2020
  11. KAPICA-TOPCZEWSKA K, Collin F, Tarasiuk J, Czarnowska A, et al
    John Cunningham Virus Status, Seroconversion Rate, and the Risk of Progressive Multifocal Leukoencephalopathy in Polish John Cunningham Virus-Seronegative Patients with Relapsing-Remitting Multiple Sclerosis.
    Eur Neurol. 2020 Oct 7:1-6. doi: 10.1159/000510849.
    PubMed     Abstract available

    January 2020
  12. DEL BRUTTO OH, Mera RM, Costa AF, Silva P, et al
    Dawson Fingers in Older Adults with Cerebral Small Vessel Disease: A Population Study.
    Eur Neurol. 2020;83:421-425.
    PubMed     Abstract available

  13. MCKENNA MC, Al-Hinai M, Bradley D, Doran E, et al
    Patients' Experiences of Remote Neurology Consultations during the COVID-19 Pandemic.
    Eur Neurol. 2020;83:622-625.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.